AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 MAR 4 - (NewsRx.com & NewsRx.net) -- The American Heart Association (AHA) recently announced new guidelines for the prevention of cardiovascular disease (CVD) in women.
Published in the February 2004 issue of Circulation, an AHA journal, the guidelines call for individualized treatment linked to whether a woman has low, intermediate, or high risk of having a heart attack in the next 10 years. That risk level is based on a standardized scoring method developed by the Framingham Heart Study. Low risk means a woman has a less than 10% chance of having a heart attack in the next 10 years, intermediate risk is a 10% to 20% chance, and high risk is a greater than 20% chance.
"This is the first major evidence-based approach to specific coronary prevention in women with recommendations based on an individual woman's level of risk," says Emory Heart Center cardiologist Nanette K. Wenger, MD, chief of Cardiology at Grady Hospital and one of the co-authors of the new guidelines.
"These guidelines are different because they are based on a thorough, systematic review of the scientific data, which shows sex does matter when it comes to cardiovascular disease. They are truly a consensus of the clinical care community, created with input from representatives from 12 professional organizations and 22 co-sponsors."
The new guidelines include a call for smoking cessation, regular physical activity, a heart-healthy diet, and weight maintenance for all women. Aspirin, angiotensin-converting enzyme (ACE) inhibitors, and beta-blockers are recommended for all high-risk women. Statin therapy is also recommended for high-risk women, even if their low-density lipoprotein (LDL) cholesterol levels are below 100 mg/dL. Niacin and fibrate therapies are given a strong recommendation for high-risk women with specific cholesterol abnormalities; supplementation with omega-3 fatty acids and folic acid may be considered in some high-risk women.
Blood pressure-lowering drugs are recommended when blood pressure is greater than or equal to 140/90 mm Hg. However, the new guidelines say blood pressure should be maintained at less than 130/80 mm Hg when a woman has blood pressure-related target end-organ damage or diabetes. For stroke prevention, warfarin is recommended for women with atrial fibrillation and intermediate or high risk for embolic stroke. If they cannot take warfarin, or if they are at low risk for stroke, they should be given aspirin.
The guidelines also state that women with diabetes should have their blood sugar carefully controlled, ...
Source: HighBeam Research, AHA issues new guidelines for preventing heart disease in women.